DCN Dx Acquires Human Biospecimen Provider BioSouthTech to Expand Patient Access

DCN Dx announced its acquisition of BioSouthTech, Inc., a human biospecimen provider headquartered near Miami with a collection network across Latin America and access to specimens from the Caribbean. The acquisition aims to broaden sample banks and patient access for drug and diagnostic research.

According to the announcement, the integration of BioSouthTech provides diagnostic developers with enhanced access to banked specimens and collection networks designed to support studies requiring diverse patient representation. Company executives noted that the expanded sourcing options cover oncology, neurology, and autoimmune disease research, including applications for liquid biopsy assays such as multi-cancer early detection and measurable residual disease tests.

Key Details of the Acquisition

• Acquired Entity: BioSouthTech, Inc., a human biospecimen provider with operations in the Miami area.
• Geographic Reach: Collection network spanning Latin America, including South America, alongside access to specimens from the Caribbean.
• Research Focus: Support for drug and diagnostic development, oncology, neurology, autoimmune diseases, and infectious diseases.
• Service Offerings: Characterized tissue, matched sets off the shelf, and prospective collections designed to protocol.

Impact on Research and Future Plans

DCN Dx stated that customers can immediately request off-the-shelf characterized tissue and matched sets or establish prospective collections aligned with specific study protocols. The company reported that its collection network currently reaches patients across various ancestries and regions, with plans for new geographies and expanded cohorts expected in early 2027.

Direct collections operate under Institutional Review Board and Independent Ethics Committee oversight, utilizing standardized protocols, clinical and demographic data, and chain-of-custody documentation. Researchers seeking to verify service availability or review detailed specifications can visit the official DCN Dx website at dcndx.com/services/biospecimen.